405-97-0

Basic information

• Product Name: (2-FLUOROETHOXY)-BENZENE
• Synonyms: (2-FLUOROETHOXY)-BENZENE
• CAS NO: 405-97-0
• Molecular Formula: C₈H₉FO
• Molecular Weight: 140.1549
• Mol File: 405-97-0.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 185.2°Cat760mmHg
• Flash Point: 64.8°C
• Appearance: /
• Density: 1.035g/cm³
• Vapor Pressure: 0.968mmHg at 25°C
• Refractive Index: 1.469
• CAS DataBase Reference: (2-FLUOROETHOXY)-BENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: (2-FLUOROETHOXY)-BENZENE(405-97-0)
• EPA Substance Registry System: (2-FLUOROETHOXY)-BENZENE(405-97-0)

Safety Data

• Hazardous Substances Data: 405-97-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H9FO/c9-6-7-10-8-4-2-1-3-5-8/h1-5H,6-7H2

Upstream product

• 762-50-5 1-chloro-2-fluoroethane 
• 139-02-6 sodium phenoxide 
• 762-49-2 2-fluoroethyl bromide 
• 108-95-2 phenol 
• 371-62-0 2-fluoroethanol 
• 71-43-2 benzene 
• 383-50-6 2-fluoroethyl tosylate 
• 369-57-3 benzenediazonium tetrafluoroborate 
• 122-99-6 2-Phenoxyethanol 
• 309-88-6 hexafluoropropene-diethylamine adduct 
• 70659-90-4 1-azido-2-phenoxyethane 
• 64-17-5 ethanol 

Downstream Products

• 264624-26-2 4-(2-fluoroethoxy)benzenesulfonyl chloride 
• 1440062-33-8 C₁₀H₁₄FNO₂ 
• 1440060-25-2 C₁₇H₁₄F₃NO₂ 
• 1440063-05-7 C₁₇H₁₆F₃NO₃ 
• 1440059-45-9 C₁₇H₁₅ClF₃NO₂ 
• 1440061-63-1 C₁₂H₁₄FNO₄ 

Relevant articles and documents

Reactions of monoesters of ethylene glycol with N,N-diethyl-1,1,2,3,3,3-hexafluoropropylamine

By reaction with 1,1,2,3,3,3-hexafluoropropyldiethylamine (PPDA), various monoesters of ethylene glycol gave a mixture of corresponding monofluorides and 2,3,3,3-tetrafluoropropionate esters. The antimicrobial properties of these fluorine compounds for a spent coolant were examined.

Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (Radio)synthesis, in vitro and first in vivo evaluation

Noninvasive imaging and quantification of matrix metalloproteinase (MMP) activity in vivo are of great (pre)clinical interest. This can potentially be realized by using radiolabeled MMP inhibitors (MMPIs) as positron emission tomography (PET) imaging agen

Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3- methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET

An approach to the in vivo imaging of locally upregulated and activated matrix metalloproteinases (MMPs) found in many pathological processes is offered by positron emission tomography (PET). Hence, appropriate PET radioligands for MMP imaging are required. Here, we describe the syntheses of novel fluorinated MMP inhibitors (MMPIs) based on lead structures of the broad-spectrum inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)-amino]-3-methyl-butanamide (CGS 25966) and N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)-amino]-3- methyl-butanamide (CGS 27023A). Additionally, tailor-made precursor compounds for radiolabeling with the positron-emitter 18F were synthesized. All prepared hydroxamate target compounds showed high in vitro MMP inhibition potencies for MMP-2, MMP-8, MMP-9, and MMP-13. As a consequence, the promising fluorinated hydroxamic acid derivative 1f was resynthesized in its 18F-labeled version via two different procedures yielding the potential PET radioligand [18F]If. As expected, the biodistribution behavior of this novel compound and that of the more hydrophilic variant [ 18F]1j, also developed by our group, indicates that there was no tissue specific accumulation in wild-type (WT) mice.